The present invention encompasses novel splice variant forms of the mu-opioid receptor-1 (MOR-1) and the polynucleotide sequences encoding the MOR-1 splice variants. The invention further encompasses methods of screening for compositions regulating the MOR-1 splice variant activities and the development of therapeutic modalities directed to regulating activity. Regulation of the MOR-1 splice variant activities may impact the physiologic process of analgesia.

 
Web www.patentalert.com

< Tripeptide of Fc.gamma.RIIA

< Regulation of endogenous gene expression in cells using zinc finger proteins

> Methods for the isolation and analysis of cellular protein content

> Methods, devices, arrays and kits for detecting and analyzing biomolecules

~ 00281